Ray-Coquard et al identified risk factors associated with early death following chemotherapy for a solid tumor or malignant lymphoma. This can help to identify a patient who may benefit from closer monitoring and more aggressive management. The authors are from multiple hospitals in France who participate in the ELYPSE Study Group.
